Invention Application
- Patent Title: TREATMENT METHODS FOR PULMONARY ARTERIAL HYPERTENSION
-
Application No.: PCT/AU2021/051134Application Date: 2021-09-29
-
Publication No.: WO2022198259A1Publication Date: 2022-09-29
- Inventor: KARIMIGALOUGAHI, Keyvan , CELERMAJER, David Stephen
- Applicant: THE HEART RESEARCH INSTITUTE LTD , THE UNIVERSITY OF SYDNEY
- Applicant Address: 7 Eliza Street; Sydney
- Assignee: THE HEART RESEARCH INSTITUTE LTD,THE UNIVERSITY OF SYDNEY
- Current Assignee: THE HEART RESEARCH INSTITUTE LTD,THE UNIVERSITY OF SYDNEY
- Current Assignee Address: 7 Eliza Street; Sydney
- Agency: FB RICE
- Priority: AU2021900882 2021-03-25
- Main IPC: A61K31/36
- IPC: A61K31/36 ; A61K31/426 ; A61K31/506 ; A61P9/02 ; A61P9/12
Abstract:
The present disclosure relates to the field of therapeutic methods for the prevention or treatment of pre-capillary pulmonary hypertension (PH), and more particularly pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension, using β3-adrenergic receptor agonists, specifically CL316243 or mirabegron.
Information query
